Jan 29, 2020

Anat Cohen-Dayag PhD chief executive officer, Compugen discusses the current immune-oncology treatment landscape, with only 20-30% of patients responding to currently available treatments, and the missing link that she believes her company may have found to improve the success rate.  Anat talks about how Compugen's...

Jan 29, 2020

Anat Cohen-Dayag PhD chief executive officer, Compugen discusses the current immune-oncology treatment landscape, with only 20-30% of patients responding to currently available treatments, and the missing link that she believes her company may have found to improve the success rate.  Anat talks about how Compugen's...

Jan 27, 2020

Ronnie Andrews, CEO, Oncocyte discusses the company's mission to answer critical questions along the cancer care continuum through the use of their molecular tests for diagnosis and treatment of early stage lung cancer.  Ronnie also talks about the changes in cancer care over the past 20 years and the potential these...

Jan 27, 2020

Ronnie Andrews, CEO, Oncocyte discusses the company's mission to answer critical questions along the cancer care continuum through the use of their molecular tests for diagnosis and treatment of early stage lung cancer.  Ronnie also talks about the changes in cancer care over the past 20 years and the potential these...

Jan 21, 2020

Brad Younggren MD, Chief Medical Officer, 98point6 talks about what happens when a company fundamentally changes the way patients interact with doctors by providing 24/7 on-line access to medical professionals aided by the camera and attachments on mobile devices to further inform the diagnosis and treatment plan.  With...